Testing naloxone for brain effects in healthy adults
Treatments studied
Part of Brain & nervous system clinical trials.
This early study tests a medicine called naloxone, given by the study, to see how it affects the brain and safety in people who are otherwise well. It may help researchers understand naloxone’s potential role in brain-related conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 65 years old
- Be able to understand the study and sign consent yourself
- Be able to have an MRI scan (no MRI safety issues)
- Have no metal implants in the head, heart, or neck, and no past brain surgery
- Have no recent or untreated major mental health, nervous system, or seizure history
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-stage study looks at how opioids affect your experience of social situations and your brain activity. It may help researchers understand how opioid medicines influence social perception and brain signaling.
This study tests if giving naloxone to adults having a heart attack outside the hospital that is likely caused by opioids can help improve outcomes. Participants will receive naloxone along with standard emergency care.
This study tests a new drug, CS-1103, to see if it can safely help reverse the effects of fentanyl (a strong opioid) even after a naloxone block. Healthy volunteers who have used opioids before will be given fentanyl and then the study drug, while researchers monitor safety and how the drug works.
This trial tests whether naloxone, a drug that blocks opioid effects, can change how your body responds to pain injections in the lower back. It may help find new ways to treat low back pain that hasn't improved with physical therapy or oral medications.
This early study tests how opioid medicine, along with social support, affects how people learn or “unlearn” certain responses. If you’re healthy and meet safety requirements, it may help researchers understand how support could change the effects of pain-related medicines on behavior.
This study tests a new medicine (ENA-001) that helps restore normal breathing when it has slowed down too much due to opioid painkillers. Healthy volunteers will receive the drug to see how safe it is and how the body handles it.
Hear when a new Analgesia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.